2007 NSTI Nanotechnology Conference and Trade Show - Nanotech 2007 - 10th Annual
Technical Conferences
Nano Electronics & Photonics
Nano Fabrication
MEMS & NEMS
Sensors & Systems
Micro & Nano Fluidics
MSM - Modeling Microsystems
WCM - Compact Modeling
Nanostructured Materials & Devices
Soft Nanotechnologies & Applications
Nanoparticles in Soft Materials - Colloidal Systems
Polymer Nanotechnology
Carbon Nano Structures & Devices
Nano Particles & Applications
Composites & Interfaces
Energy Technologies & Applications
Nanotech in Health, Environment & Society
ICCN - Nanoscale Modeling
Nanoscale Characterization
Homeland Security
Bio Nano Materials & Tissues
Bio Sensors & Diagnostics
Biomarkers & Nanoparticles
Cancer Diagnostics, Imaging & Treatment
Drug Delivery & Therapeutics
Nano Medicine
Nanotech to Neurology
TechConnect Summit - IP Matchmaking
Cleantech 2007
Industrial Impact Workshop
Program Committee

Nanotech in Health, Environment & Society

Nanotech in Health, Environment & Society

In Collaboration With

FDA Nano Science and Technology Institute
Greenberg Traurig Small Times

Confirmed Speakers

Linda M. Katz
Linda M. Katz
Director, Office of Cosmetics and Colors
Food and Drug Administration (FDA)
Patrick Soon-Shiong
Patrick Soon-Shiong
Chairman and Chief Executive Officer
Abraxis BioScience
Larry Gibbs
Larry Gibbs
Associate Vice Provost for Environmental Health & Safety
Stanford University
Lynn E. Foster
Lynn E. Foster
Emerging Technologies Director
Greenberg Traurig, LLP
Vladimir V. Murashov
Vladimir V. Murashov
Special Assistant to the Director
National Institute for Occupational Safety and Health
Celia Merzbacher
Celia Merzbacher
Office of Science and Technology Policy (OSTP)
Executive Office of the President
Scott E. McNeil
Scott E. McNeil
Director, Nanotechnology Characterization Laboratory
National Cancer Institute
Thomas F. Myers
Thomas F. Myers
Counsel, Environment, Technology & Regulatory Affairs
U.S. Chamber of Commerce
Caroline Baier-Anderson
Caroline Baier-Anderson
Health Scientist
Environmental Defense
Richard C. Pleus
Richard C. Pleus
Director and Toxicologist
Intertox, Inc.

Symposium Sessions

 

Monday May 21

7:00 Registration
8:30 Nanotech Conference Opening & Keynotes
10:30 Environment, Health and Society: Regulatory & Social Implications
10:40 Environment, Health and Society: Regulatory & Social Implications
1:30 Environment, Health and Society: Drug Delivery
2:00 Environment, Health and Society: Drug Delivery Testing Panel
3:00 Environment, Health and Society: Standards and Testing
4:00 Environment, Health and Society: Occupational Heath & Safety
4:00 Environment, Health and Society: Occupational Heath & Safety Panel
 

Tuesday May 22

7:00 TUESDAY - Registration
4:00 Poster Session 1 (4:00 - 6:00) & Expo Reception
 

Wednesday May 23

1:00 Toxicology Studies in Nanotechnology - 1
2:00 Nanotech Poster Session 2 - Expo Reception (2:00 - 4:00)
4:00 Toxicology Studies in Nanotechnology - 2
 

Thursday May 24

10:30 Nanotechnology: Regulation, Risk and Framework
 

Symposium Program

 

Monday May 21

Back to Top
7:00 RegistrationMain Lobby
Back to Top
8:30 Nanotech Conference Opening & KeynotesGrand Ballroom
 Session chair: Bart Romanowicz, NSTI, Andreas Wild, Freescale Semiconductors
8:30 How the US Can Ensure Energy Supply for the Future
J. Hofmeister, Shell Oil, US (bio)
9:10 National Nanotech Initiative and Industrial Nanotechnology Impact
A.H. Carim, Co-Chair, Nanoscale Science and Engineering Technology, Subcommittee, National Science & Technology Council, U.S. Department of Energy, US (bio)
Back to Top
10:30 Environment, Health and Society: Regulatory & Social ImplicationsRoom 204
 Session chair: Lynn Foster, Greenberg Traurig, US
10:30 Opening Remarks
L. Foster, Greenberg Traurig, US (bio)
Back to Top
10:40 Environment, Health and Society: Regulatory & Social ImplicationsRoom 204
 Session chair: Lynn Foster, Greenberg Traurig, US
- T. Meyers, US Chamber of Commerce, US
- C. Baier-Anderson, Enviromental Defense, US
- V. Murashov, US NIOSH, US
- J. Alwood, US EPA, US
Back to Top
1:30 Environment, Health and Society: Drug DeliveryRoom 204
 Session chair: Lynn Foster, Greenberg Traurig, US
1:30 Drug Delivery through Nanotechnology
P. Soong-Shiong, Abraxis Biosience, US
Back to Top
2:00 Environment, Health and Society: Drug Delivery Testing PanelRoom 204
 Session chair: Lynn Foster, Greenberg Traurig, US
- S.E. McNeil, National Cancer Institute, US
- M. Analoui, Pfizer, US
- P. Soong-Shiong, Abraxis Bioscience, US
- P. Krüger, Bayer, DE
Back to Top
3:00 Environment, Health and Society: Standards and TestingRoom 204
 Session chair: Lynn Foster, Greenberg Traurig, US
- S. Brown, Intel Corporation, US
- S. McNeil, National Cancer Institute, US
- A. Nel, UCLA, US
- R. Pleus, Intertox, US
Back to Top
4:00 Environment, Health and Society: Occupational Heath & SafetyRoom 204
 Session chair: Patti Glaza, Smalltimes, US
4:00 Regulatory and Risk Overview FDA Perspective
L. Katz, FDA, US
Back to Top
4:00 Environment, Health and Society: Occupational Heath & Safety PanelRoom 204
 Session chair: Patti Glaza, Smalltimes, US
- L.M. Gibbs, Stanford University, US
- L. Katz, FDA, US
- T. Maher, Altair Nanotechnologies, US
 

Tuesday May 22

Back to Top
7:00 TUESDAY - RegistrationMain Lobby
Back to Top
4:00 Poster Session 1 (4:00 - 6:00) & Expo ReceptionExhibit Hall
 

Wednesday May 23

Back to Top
1:00 Toxicology Studies in Nanotechnology - 1Grand Ballroom H
 Session chair: Srinvas Iyer, LANL, US
1:00 Cytotoxicity of Dental Nanocomposite Particles
E.L. Kostoryz, C.J. Utter, Y. Wang, V. Dusevich and P. Spencer, University of Missouri-Kansas City, US
1:20 An OMICs Approach for Assessing the Safety of Single-Walled Carbon Nanotubes in Human Skin and Lung Cells
M.J. Cunningham, M. Shah, C. Lema, S. Magnuson, M. Falduto, L. Balzano and D. Resasco, Houston Advanced Research Center, US
1:40 Toxicogenomics study of nanomaterials on the model organism zebrafish
I. Rojo, M. Uriarte, I. Obieta, I. Bustero, A. Egizabal, M.A. Pardo and O. Martínez de Ilárduya, Azti-Tecnalia, ES
2:00 Stable Isotope Tracing - a way forward for Nanotechnology?
B. Gulson, H. Wong, M. McCall, S. Danon, G. Greenoak, J. Trotter, P. Casey and J. Stauber, Commonwealth Scientifc and Industrial Research Organisation, AU
2:20 An integrated NMR/nanosensor system for sensitive detection of environmental toxins and harmful microbes
J.M. Perez, D.P. Fries and J.J. Hickman, University of Central Florida, US
Back to Top
2:00 Nanotech Poster Session 2 - Expo Reception (2:00 - 4:00)Exhibit Hall
Back to Top
4:00 Toxicology Studies in Nanotechnology - 2Grand Ballroom H
 Session chair: Chinh Pham, Greenberg Traurig, US
4:00 Biodistribution and Toxicity of Nanomaterials In Vivo: Effects of Composition, Size, Surface Functionalization and Route of Exposure
S.L. Harper, B. Maddux, J. Hutchison and R.L. Tanguay, Oregon State University, US
4:20 Differential Cytotoxicity of Metal Oxide Nanoparticles
J. Chen, J. Zhu, H.-H. Cho, K. Cui, F. Li, X. Zhou, J.T. Rogers, S.T.C. Wong and X. Huang, Brigham and Women's Hospital, Harvard Medical School, US
4:40 Cell-based Assays for Cytotoxic and Pro-inflammatory Effects of Gold Nanoparticles.
T. Knight, S.S. Wise, M.D. Mason, J.P. Wise_Sr. and A-K. Ng, University of Southern Maine, US
5:00 Fate, Transport, and Toxicity of Nanomaterials in Drinking Water
Y. Zhang, B.A. Koeneman, Y. Chen, P. Westerhoff, D.G. Capco and J. Crittenden, Arizona State University, US
5:20 Interaction of carbon nanotube material with rat skin by 21 T MRI
R. Sharma, K. Shetty, R. Liang and C.J. Chen, Florida State University, US
 

Thursday May 24

Back to Top
10:30 Nanotechnology: Regulation, Risk and FrameworkRoom 201
 Session chair: John Monica, Sponsored by Porter Wright Morris & Arthur LLP
10:30 Nanotechnology: Regulation, Risk and Framework
J.C. Monica, Porter Wright Morris & Arthur LLP, US (bio)
11:00 A Framework for Responsible Nanotechnology
S. Walsh and T. Medley, Environmental Defense, US
11:20 Risk Identification and Assessment Techniques in the Absence of Toxicology Data on Nanomaterials
A. Wardak, S. Deshpande, N. Swami and M. Gorman, University of Virginia, US
11:40 Health Risk Assessment of Products Containing Nano-engineered Materials
F.S. Mowat, A.L. Hartzell, M.G. da Silva and J.S. Tsuji, Exponent, US
 

Special Symposium

NSTI is proud to collaborate with the Food and Drug Administration (FDA) and Small Times Media in presenting a Special Symposium on Nanotechnology in Health, Environment & Society, with a focus towards:

“Exploring opportunities to foster innovation using nanotechnology materials to develop safe and effective drugs, biologics and devices, and to develop safe foods, feeds, and cosmetics.”

Consistent with the scientific origins of the conference, this symposium provides a forum to present the societal, health, and environmental benefits and safety concerns presented by nanotechnology, and to discuss regulatory, health and policy issues surrounding the rapid development and commercialization of these technologies. Presentations will include technical and commercial breakthroughs along with addressing of societal issues by industry, government and environmental organizations. Goals include:

  • Establish a strong base of understanding about the best thinking on the safety, health, environmental and social implications of nanotech;
  • Engage the mainstream science and business community on the full range of topics associated with these issues;
  • Become a key gathering place for the community of people and institutions interested in the safety, environmental and social implications of nanotechnology.
  • Continue to strengthen FDA's collaborative relationships with other federal agencies, including the agencies participating in the National Nanotechnology Initiative such as the NIH, EPA, USDA, as well as with foreign government regulatory bodies, international organizations, healthcare professionals, industry, consumers, and other stakeholders to gather information regarding nanotechnology materials used or that could be used in FDA-regulated products.
  • Consider appropriate vehicles for communicating with the public about the use of nanotechnology materials in FDA-regulated products.

Topics & Application Areas

Online abstract submissions are now being accepted. Proposed topics include, but are not be limited to:

  • Food & Feed Access & Production
  • Cosmetics & Drug Access & Production
  • Environmental Improvement Applications
  • Water Access & Purification
  • Toxicology Research
  • Societal Improvement Applications
  • Ethical Consideration
  • Social Policy Considerations
  • Other

Journal Submissions

Journal of Experimental Nanoscience

Journal of Experimental Nanoscience

Selected Nanotech Proceedings papers will be reviewed and invited into a Special Issue of the Journal of Experimental Nanoscience. The journal provides a showcase for advances in the experimental sciences underlying nanotechnology and nanomaterials.

For consideration into this Special Issue of the Journal of Experimental Nanoscience, please select the “Submit to Journal of Experimental Nanoscience” button during the on-line submission procedure. You may only select a single journal during the submission process.

Journal of Nanoparticle Research

Journal of Nanoparticle Research

Selected Nanotech Proceedings papers will be reviewed and invited into a Special Issue of Journal of Nanoparticle Research. The journal disseminates knowledge of the physical, chemical and biological phenomena and processes in nanoscale structures.

For consideration into this Special Issue of Journal of Nanoparticle Research, please select the “Submit to Journal of Nanoparticle Research” button during the on-line submission procedure. You may only select a single journal during the submission process.


Symposium Coordinator

Matthew Laudon
Nano Science and Technology Institute

Conference Quick Links

 
 

Names, and logos of other organizations are the property of those organizations and not of NSTI.
This event is not open to the general public and NSTI reserves the right to refuse admission and participation to any individual.